nodes	percent_of_prediction	percent_of_DWPC	metapath
Amprenavir—Cytochrome P450 3A4 Inhibitors—Everolimus—kidney cancer	0.292	0.5	CiPCiCtD
Amprenavir—Cytochrome P450 3A4 Inhibitors—Pazopanib—kidney cancer	0.292	0.5	CiPCiCtD
Amprenavir—ABCB1—kidney cancer	0.0728	1	CbGaD
Amprenavir—ABCC1—Dactinomycin—kidney cancer	0.0209	0.0782	CbGbCtD
Amprenavir—CYP3A5—Temsirolimus—kidney cancer	0.0162	0.0604	CbGbCtD
Amprenavir—ABCC1—Paclitaxel—kidney cancer	0.015	0.0559	CbGbCtD
Amprenavir—ABCC1—Vinblastine—kidney cancer	0.0131	0.049	CbGbCtD
Amprenavir—ABCC1—Vincristine—kidney cancer	0.0129	0.0482	CbGbCtD
Amprenavir—ABCB1—Temsirolimus—kidney cancer	0.0105	0.0393	CbGbCtD
Amprenavir—CYP2D6—Temsirolimus—kidney cancer	0.00991	0.037	CbGbCtD
Amprenavir—CYP3A4—Everolimus—kidney cancer	0.00933	0.0349	CbGbCtD
Amprenavir—CYP2C8—Pazopanib—kidney cancer	0.00816	0.0305	CbGbCtD
Amprenavir—ABCC1—Doxorubicin—kidney cancer	0.00806	0.0301	CbGbCtD
Amprenavir—CYP3A4—Temsirolimus—kidney cancer	0.0063	0.0235	CbGbCtD
Amprenavir—CYP2B6—Sorafenib—kidney cancer	0.00625	0.0234	CbGbCtD
Amprenavir—CYP3A5—Erlotinib—kidney cancer	0.00606	0.0226	CbGbCtD
Amprenavir—CYP2C9—Capecitabine—kidney cancer	0.00594	0.0222	CbGbCtD
Amprenavir—CYP2C8—Erlotinib—kidney cancer	0.00583	0.0218	CbGbCtD
Amprenavir—CYP3A5—Paclitaxel—kidney cancer	0.00555	0.0207	CbGbCtD
Amprenavir—ABCB1—Pazopanib—kidney cancer	0.00553	0.0206	CbGbCtD
Amprenavir—CYP2C8—Paclitaxel—kidney cancer	0.00533	0.0199	CbGbCtD
Amprenavir—CYP2D6—Pazopanib—kidney cancer	0.00521	0.0194	CbGbCtD
Amprenavir—ABCB1—Dactinomycin—kidney cancer	0.00505	0.0189	CbGbCtD
Amprenavir—CYP3A5—Sorafenib—kidney cancer	0.00493	0.0184	CbGbCtD
Amprenavir—CYP3A5—Vincristine—kidney cancer	0.00478	0.0179	CbGbCtD
Amprenavir—CYP2C8—Sorafenib—kidney cancer	0.00474	0.0177	CbGbCtD
Amprenavir—ABCB1—Gemcitabine—kidney cancer	0.004	0.0149	CbGbCtD
Amprenavir—CYP3A5—Sunitinib—kidney cancer	0.00399	0.0149	CbGbCtD
Amprenavir—CYP2C19—Sorafenib—kidney cancer	0.00397	0.0148	CbGbCtD
Amprenavir—ABCB1—Erlotinib—kidney cancer	0.00394	0.0147	CbGbCtD
Amprenavir—CYP2B6—Doxorubicin—kidney cancer	0.00379	0.0142	CbGbCtD
Amprenavir—CYP2C9—Paclitaxel—kidney cancer	0.00372	0.0139	CbGbCtD
Amprenavir—CYP2D6—Erlotinib—kidney cancer	0.00372	0.0139	CbGbCtD
Amprenavir—ABCB1—Paclitaxel—kidney cancer	0.00361	0.0135	CbGbCtD
Amprenavir—CYP3A4—Pazopanib—kidney cancer	0.00331	0.0124	CbGbCtD
Amprenavir—CYP2C9—Sorafenib—kidney cancer	0.0033	0.0123	CbGbCtD
Amprenavir—ABCB1—Sorafenib—kidney cancer	0.00321	0.012	CbGbCtD
Amprenavir—ABCB1—Vinblastine—kidney cancer	0.00317	0.0118	CbGbCtD
Amprenavir—ABCB1—Vincristine—kidney cancer	0.00311	0.0116	CbGbCtD
Amprenavir—CYP2D6—Sorafenib—kidney cancer	0.00302	0.0113	CbGbCtD
Amprenavir—CYP2D6—Vinblastine—kidney cancer	0.00298	0.0111	CbGbCtD
Amprenavir—ABCB1—Sunitinib—kidney cancer	0.0026	0.0097	CbGbCtD
Amprenavir—CYP3A4—Erlotinib—kidney cancer	0.00236	0.00882	CbGbCtD
Amprenavir—CYP3A4—Paclitaxel—kidney cancer	0.00216	0.00808	CbGbCtD
Amprenavir—ABCB1—Doxorubicin—kidney cancer	0.00195	0.00727	CbGbCtD
Amprenavir—CYP3A4—Sorafenib—kidney cancer	0.00192	0.00718	CbGbCtD
Amprenavir—CYP3A4—Vinblastine—kidney cancer	0.0019	0.00709	CbGbCtD
Amprenavir—CYP3A4—Vincristine—kidney cancer	0.00186	0.00697	CbGbCtD
Amprenavir—CYP2D6—Doxorubicin—kidney cancer	0.00183	0.00685	CbGbCtD
Amprenavir—CYP3A4—Sunitinib—kidney cancer	0.00156	0.00581	CbGbCtD
Amprenavir—CYP3A4—Doxorubicin—kidney cancer	0.00117	0.00435	CbGbCtD
Amprenavir—CYP2C19—urine—kidney cancer	0.000788	0.156	CbGeAlD
Amprenavir—CYP2C9—urine—kidney cancer	0.000611	0.121	CbGeAlD
Amprenavir—CYP3A4—urine—kidney cancer	0.000466	0.092	CbGeAlD
Amprenavir—CYP2D6—urine—kidney cancer	0.000458	0.0905	CbGeAlD
Amprenavir—ABCC1—cortex of kidney—kidney cancer	0.000186	0.0367	CbGeAlD
Amprenavir—ABCC1—cardiac atrium—kidney cancer	0.000177	0.0349	CbGeAlD
Amprenavir—CYP2C8—renal system—kidney cancer	0.000168	0.0332	CbGeAlD
Amprenavir—CYP3A5—nephron tubule—kidney cancer	0.000167	0.033	CbGeAlD
Amprenavir—CYP2B6—nephron tubule—kidney cancer	0.000166	0.0328	CbGeAlD
Amprenavir—CYP2C8—kidney—kidney cancer	0.000163	0.0321	CbGeAlD
Amprenavir—CYP3A5—renal system—kidney cancer	0.000152	0.03	CbGeAlD
Amprenavir—CYP2B6—renal system—kidney cancer	0.000151	0.0298	CbGeAlD
Amprenavir—CYP3A5—kidney—kidney cancer	0.000147	0.029	CbGeAlD
Amprenavir—CYP2B6—kidney—kidney cancer	0.000146	0.0288	CbGeAlD
Amprenavir—CYP3A5—cortex of kidney—kidney cancer	0.000143	0.0282	CbGeAlD
Amprenavir—CYP2B6—gonad—kidney cancer	0.000135	0.0267	CbGeAlD
Amprenavir—CYP3A4—renal system—kidney cancer	0.000114	0.0225	CbGeAlD
Amprenavir—CYP2D6—renal system—kidney cancer	0.000112	0.0221	CbGeAlD
Amprenavir—CYP3A4—kidney—kidney cancer	0.00011	0.0218	CbGeAlD
Amprenavir—Myalgia—Sorafenib—kidney cancer	0.000109	0.00182	CcSEcCtD
Amprenavir—Paraesthesia—Vinblastine—kidney cancer	0.000109	0.00181	CcSEcCtD
Amprenavir—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—kidney cancer	0.000109	0.00181	CcSEcCtD
Amprenavir—Paraesthesia—Everolimus—kidney cancer	0.000108	0.0018	CcSEcCtD
Amprenavir—CYP2D6—kidney—kidney cancer	0.000108	0.0214	CbGeAlD
Amprenavir—Pruritus—Pazopanib—kidney cancer	0.000108	0.0018	CcSEcCtD
Amprenavir—Erythema multiforme—Gemcitabine—kidney cancer	0.000108	0.00179	CcSEcCtD
Amprenavir—Hyperglycaemia—Paclitaxel—kidney cancer	0.000108	0.00179	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Erlotinib—kidney cancer	0.000106	0.00177	CcSEcCtD
Amprenavir—Depression—Paclitaxel—kidney cancer	0.000106	0.00176	CcSEcCtD
Amprenavir—Cardiac disorder—Gemcitabine—kidney cancer	0.000106	0.00176	CcSEcCtD
Amprenavir—Decreased appetite—Vinblastine—kidney cancer	0.000105	0.00175	CcSEcCtD
Amprenavir—Stevens-Johnson syndrome—Paclitaxel—kidney cancer	0.000105	0.00175	CcSEcCtD
Amprenavir—Myalgia—Sunitinib—kidney cancer	0.000105	0.00175	CcSEcCtD
Amprenavir—Mental disorder—Vincristine—kidney cancer	0.000105	0.00175	CcSEcCtD
Amprenavir—Decreased appetite—Everolimus—kidney cancer	0.000105	0.00175	CcSEcCtD
Amprenavir—Acute coronary syndrome—Paclitaxel—kidney cancer	0.000105	0.00174	CcSEcCtD
Amprenavir—Diarrhoea—Pazopanib—kidney cancer	0.000105	0.00174	CcSEcCtD
Amprenavir—Unspecified disorder of skin and subcutaneous tissue—Sunitinib—kidney cancer	0.000105	0.00174	CcSEcCtD
Amprenavir—Liver function test abnormal—Capecitabine—kidney cancer	0.000104	0.00174	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Everolimus—kidney cancer	0.000104	0.00174	CcSEcCtD
Amprenavir—Myocardial infarction—Paclitaxel—kidney cancer	0.000104	0.00173	CcSEcCtD
Amprenavir—Fatigue—Everolimus—kidney cancer	0.000104	0.00173	CcSEcCtD
Amprenavir—Inflammation—Doxorubicin—kidney cancer	0.000104	0.00172	CcSEcCtD
Amprenavir—Vomiting—Temsirolimus—kidney cancer	0.000103	0.00172	CcSEcCtD
Amprenavir—Nervous system disorder—Sorafenib—kidney cancer	0.000103	0.00171	CcSEcCtD
Amprenavir—Rash—Temsirolimus—kidney cancer	0.000102	0.0017	CcSEcCtD
Amprenavir—Dermatitis—Temsirolimus—kidney cancer	0.000102	0.0017	CcSEcCtD
Amprenavir—Aspartate aminotransferase increased—Capecitabine—kidney cancer	0.000102	0.0017	CcSEcCtD
Amprenavir—Skin disorder—Sorafenib—kidney cancer	0.000102	0.00169	CcSEcCtD
Amprenavir—Headache—Temsirolimus—kidney cancer	0.000102	0.00169	CcSEcCtD
Amprenavir—Decreased appetite—Erlotinib—kidney cancer	0.000101	0.00169	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Erlotinib—kidney cancer	0.000101	0.00167	CcSEcCtD
Amprenavir—Hepatobiliary disease—Paclitaxel—kidney cancer	0.0001	0.00167	CcSEcCtD
Amprenavir—Fatigue—Erlotinib—kidney cancer	0.0001	0.00167	CcSEcCtD
Amprenavir—Anorexia—Sorafenib—kidney cancer	9.99e-05	0.00166	CcSEcCtD
Amprenavir—Alanine aminotransferase increased—Capecitabine—kidney cancer	9.98e-05	0.00166	CcSEcCtD
Amprenavir—Myalgia—Dactinomycin—kidney cancer	9.96e-05	0.00166	CcSEcCtD
Amprenavir—Gastrointestinal pain—Vinblastine—kidney cancer	9.91e-05	0.00165	CcSEcCtD
Amprenavir—Nervous system disorder—Sunitinib—kidney cancer	9.89e-05	0.00165	CcSEcCtD
Amprenavir—Gastrointestinal pain—Everolimus—kidney cancer	9.88e-05	0.00164	CcSEcCtD
Amprenavir—Discomfort—Dactinomycin—kidney cancer	9.84e-05	0.00164	CcSEcCtD
Amprenavir—Skin disorder—Sunitinib—kidney cancer	9.8e-05	0.00163	CcSEcCtD
Amprenavir—Vomiting—Pazopanib—kidney cancer	9.73e-05	0.00162	CcSEcCtD
Amprenavir—Rash—Pazopanib—kidney cancer	9.64e-05	0.0016	CcSEcCtD
Amprenavir—Nausea—Temsirolimus—kidney cancer	9.64e-05	0.0016	CcSEcCtD
Amprenavir—Dermatitis—Pazopanib—kidney cancer	9.64e-05	0.0016	CcSEcCtD
Amprenavir—Anorexia—Sunitinib—kidney cancer	9.62e-05	0.0016	CcSEcCtD
Amprenavir—Abdominal pain—Vinblastine—kidney cancer	9.58e-05	0.00159	CcSEcCtD
Amprenavir—Headache—Pazopanib—kidney cancer	9.58e-05	0.00159	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Sorafenib—kidney cancer	9.55e-05	0.00159	CcSEcCtD
Amprenavir—Abdominal pain—Everolimus—kidney cancer	9.55e-05	0.00159	CcSEcCtD
Amprenavir—Gastrointestinal pain—Erlotinib—kidney cancer	9.53e-05	0.00159	CcSEcCtD
Amprenavir—Abdominal discomfort—Capecitabine—kidney cancer	9.38e-05	0.00156	CcSEcCtD
Amprenavir—Connective tissue disorder—Paclitaxel—kidney cancer	9.37e-05	0.00156	CcSEcCtD
Amprenavir—Abdominal pain—Erlotinib—kidney cancer	9.21e-05	0.00153	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Sunitinib—kidney cancer	9.19e-05	0.00153	CcSEcCtD
Amprenavir—Neutropenia—Capecitabine—kidney cancer	9.15e-05	0.00152	CcSEcCtD
Amprenavir—Decreased appetite—Sorafenib—kidney cancer	9.11e-05	0.00152	CcSEcCtD
Amprenavir—Anorexia—Dactinomycin—kidney cancer	9.1e-05	0.00151	CcSEcCtD
Amprenavir—Nausea—Pazopanib—kidney cancer	9.09e-05	0.00151	CcSEcCtD
Amprenavir—Paraesthesia—Sunitinib—kidney cancer	9.06e-05	0.00151	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Sorafenib—kidney cancer	9.05e-05	0.00151	CcSEcCtD
Amprenavir—Fatigue—Sorafenib—kidney cancer	9.04e-05	0.0015	CcSEcCtD
Amprenavir—Erythema multiforme—Paclitaxel—kidney cancer	9.02e-05	0.0015	CcSEcCtD
Amprenavir—Myalgia—Vincristine—kidney cancer	8.9e-05	0.00148	CcSEcCtD
Amprenavir—ABCB1—nephron tubule—kidney cancer	8.87e-05	0.0175	CbGeAlD
Amprenavir—Cardiac disorder—Paclitaxel—kidney cancer	8.85e-05	0.00147	CcSEcCtD
Amprenavir—Hyperglycaemia—Capecitabine—kidney cancer	8.82e-05	0.00147	CcSEcCtD
Amprenavir—Decreased appetite—Sunitinib—kidney cancer	8.77e-05	0.00146	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Sunitinib—kidney cancer	8.71e-05	0.00145	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Dactinomycin—kidney cancer	8.7e-05	0.00145	CcSEcCtD
Amprenavir—Asthenia—Vinblastine—kidney cancer	8.7e-05	0.00145	CcSEcCtD
Amprenavir—Fatigue—Sunitinib—kidney cancer	8.7e-05	0.00145	CcSEcCtD
Amprenavir—Depression—Capecitabine—kidney cancer	8.69e-05	0.00145	CcSEcCtD
Amprenavir—Asthenia—Everolimus—kidney cancer	8.67e-05	0.00144	CcSEcCtD
Amprenavir—Stevens-Johnson syndrome—Capecitabine—kidney cancer	8.65e-05	0.00144	CcSEcCtD
Amprenavir—Acute coronary syndrome—Capecitabine—kidney cancer	8.6e-05	0.00143	CcSEcCtD
Amprenavir—Gastrointestinal pain—Sorafenib—kidney cancer	8.57e-05	0.00143	CcSEcCtD
Amprenavir—Myocardial infarction—Capecitabine—kidney cancer	8.55e-05	0.00142	CcSEcCtD
Amprenavir—Pruritus—Everolimus—kidney cancer	8.54e-05	0.00142	CcSEcCtD
Amprenavir—Myalgia—Gemcitabine—kidney cancer	8.44e-05	0.00141	CcSEcCtD
Amprenavir—Diabetes mellitus—Doxorubicin—kidney cancer	8.39e-05	0.0014	CcSEcCtD
Amprenavir—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—kidney cancer	8.39e-05	0.0014	CcSEcCtD
Amprenavir—Nervous system disorder—Vincristine—kidney cancer	8.37e-05	0.00139	CcSEcCtD
Amprenavir—Asthenia—Erlotinib—kidney cancer	8.36e-05	0.00139	CcSEcCtD
Amprenavir—Mental disorder—Paclitaxel—kidney cancer	8.36e-05	0.00139	CcSEcCtD
Amprenavir—Discomfort—Gemcitabine—kidney cancer	8.34e-05	0.00139	CcSEcCtD
Amprenavir—Malnutrition—Paclitaxel—kidney cancer	8.3e-05	0.00138	CcSEcCtD
Amprenavir—Decreased appetite—Dactinomycin—kidney cancer	8.3e-05	0.00138	CcSEcCtD
Amprenavir—Diarrhoea—Vinblastine—kidney cancer	8.3e-05	0.00138	CcSEcCtD
Amprenavir—Abdominal pain—Sorafenib—kidney cancer	8.29e-05	0.00138	CcSEcCtD
Amprenavir—Diarrhoea—Everolimus—kidney cancer	8.26e-05	0.00138	CcSEcCtD
Amprenavir—Gastrointestinal pain—Sunitinib—kidney cancer	8.25e-05	0.00137	CcSEcCtD
Amprenavir—Hepatobiliary disease—Capecitabine—kidney cancer	8.25e-05	0.00137	CcSEcCtD
Amprenavir—Pruritus—Erlotinib—kidney cancer	8.24e-05	0.00137	CcSEcCtD
Amprenavir—Fatigue—Dactinomycin—kidney cancer	8.23e-05	0.00137	CcSEcCtD
Amprenavir—Flatulence—Paclitaxel—kidney cancer	8.18e-05	0.00136	CcSEcCtD
Amprenavir—Anorexia—Vincristine—kidney cancer	8.13e-05	0.00135	CcSEcCtD
Amprenavir—ABCB1—renal system—kidney cancer	8.07e-05	0.0159	CbGeAlD
Amprenavir—Abdominal pain—Sunitinib—kidney cancer	7.97e-05	0.00133	CcSEcCtD
Amprenavir—Diarrhoea—Erlotinib—kidney cancer	7.97e-05	0.00133	CcSEcCtD
Amprenavir—Nervous system disorder—Gemcitabine—kidney cancer	7.94e-05	0.00132	CcSEcCtD
Amprenavir—Skin disorder—Gemcitabine—kidney cancer	7.86e-05	0.00131	CcSEcCtD
Amprenavir—Gastrointestinal pain—Dactinomycin—kidney cancer	7.81e-05	0.0013	CcSEcCtD
Amprenavir—ABCB1—kidney—kidney cancer	7.8e-05	0.0154	CbGeAlD
Amprenavir—Tremor—Paclitaxel—kidney cancer	7.78e-05	0.00129	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Vincristine—kidney cancer	7.77e-05	0.00129	CcSEcCtD
Amprenavir—Anorexia—Gemcitabine—kidney cancer	7.72e-05	0.00128	CcSEcCtD
Amprenavir—Vomiting—Vinblastine—kidney cancer	7.71e-05	0.00128	CcSEcCtD
Amprenavir—Connective tissue disorder—Capecitabine—kidney cancer	7.69e-05	0.00128	CcSEcCtD
Amprenavir—Vomiting—Everolimus—kidney cancer	7.68e-05	0.00128	CcSEcCtD
Amprenavir—Paraesthesia—Vincristine—kidney cancer	7.66e-05	0.00128	CcSEcCtD
Amprenavir—Rash—Everolimus—kidney cancer	7.61e-05	0.00127	CcSEcCtD
Amprenavir—Dermatitis—Everolimus—kidney cancer	7.61e-05	0.00127	CcSEcCtD
Amprenavir—Headache—Vinblastine—kidney cancer	7.6e-05	0.00126	CcSEcCtD
Amprenavir—ABCB1—cortex of kidney—kidney cancer	7.59e-05	0.015	CbGeAlD
Amprenavir—Angioedema—Paclitaxel—kidney cancer	7.59e-05	0.00126	CcSEcCtD
Amprenavir—Headache—Everolimus—kidney cancer	7.57e-05	0.00126	CcSEcCtD
Amprenavir—Abdominal pain—Dactinomycin—kidney cancer	7.55e-05	0.00126	CcSEcCtD
Amprenavir—Asthenia—Sorafenib—kidney cancer	7.52e-05	0.00125	CcSEcCtD
Amprenavir—Decreased appetite—Vincristine—kidney cancer	7.42e-05	0.00123	CcSEcCtD
Amprenavir—Pruritus—Sorafenib—kidney cancer	7.42e-05	0.00123	CcSEcCtD
Amprenavir—Vomiting—Erlotinib—kidney cancer	7.41e-05	0.00123	CcSEcCtD
Amprenavir—Erythema multiforme—Capecitabine—kidney cancer	7.4e-05	0.00123	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Gemcitabine—kidney cancer	7.37e-05	0.00123	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Vincristine—kidney cancer	7.37e-05	0.00123	CcSEcCtD
Amprenavir—Fatigue—Vincristine—kidney cancer	7.36e-05	0.00122	CcSEcCtD
Amprenavir—Rash—Erlotinib—kidney cancer	7.35e-05	0.00122	CcSEcCtD
Amprenavir—Dermatitis—Erlotinib—kidney cancer	7.34e-05	0.00122	CcSEcCtD
Amprenavir—Headache—Erlotinib—kidney cancer	7.3e-05	0.00121	CcSEcCtD
Amprenavir—Paraesthesia—Gemcitabine—kidney cancer	7.27e-05	0.00121	CcSEcCtD
Amprenavir—Cardiac disorder—Capecitabine—kidney cancer	7.26e-05	0.00121	CcSEcCtD
Amprenavir—Asthenia—Sunitinib—kidney cancer	7.24e-05	0.0012	CcSEcCtD
Amprenavir—ABCB1—gonad—kidney cancer	7.23e-05	0.0143	CbGeAlD
Amprenavir—Nausea—Vinblastine—kidney cancer	7.2e-05	0.0012	CcSEcCtD
Amprenavir—Nausea—Everolimus—kidney cancer	7.17e-05	0.00119	CcSEcCtD
Amprenavir—Diarrhoea—Sorafenib—kidney cancer	7.17e-05	0.00119	CcSEcCtD
Amprenavir—Pruritus—Sunitinib—kidney cancer	7.14e-05	0.00119	CcSEcCtD
Amprenavir—Myalgia—Paclitaxel—kidney cancer	7.07e-05	0.00118	CcSEcCtD
Amprenavir—Decreased appetite—Gemcitabine—kidney cancer	7.04e-05	0.00117	CcSEcCtD
Amprenavir—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	7.02e-05	0.00117	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Gemcitabine—kidney cancer	6.99e-05	0.00116	CcSEcCtD
Amprenavir—Discomfort—Paclitaxel—kidney cancer	6.98e-05	0.00116	CcSEcCtD
Amprenavir—Fatigue—Gemcitabine—kidney cancer	6.98e-05	0.00116	CcSEcCtD
Amprenavir—Gastrointestinal pain—Vincristine—kidney cancer	6.98e-05	0.00116	CcSEcCtD
Amprenavir—Nausea—Erlotinib—kidney cancer	6.92e-05	0.00115	CcSEcCtD
Amprenavir—Diarrhoea—Sunitinib—kidney cancer	6.9e-05	0.00115	CcSEcCtD
Amprenavir—Mental disorder—Capecitabine—kidney cancer	6.86e-05	0.00114	CcSEcCtD
Amprenavir—Asthenia—Dactinomycin—kidney cancer	6.85e-05	0.00114	CcSEcCtD
Amprenavir—Malnutrition—Capecitabine—kidney cancer	6.81e-05	0.00113	CcSEcCtD
Amprenavir—Abdominal pain—Vincristine—kidney cancer	6.75e-05	0.00112	CcSEcCtD
Amprenavir—Liver function test abnormal—Doxorubicin—kidney cancer	6.73e-05	0.00112	CcSEcCtD
Amprenavir—Flatulence—Capecitabine—kidney cancer	6.71e-05	0.00112	CcSEcCtD
Amprenavir—Vomiting—Sorafenib—kidney cancer	6.67e-05	0.00111	CcSEcCtD
Amprenavir—Nervous system disorder—Paclitaxel—kidney cancer	6.65e-05	0.00111	CcSEcCtD
Amprenavir—Rash—Sorafenib—kidney cancer	6.61e-05	0.0011	CcSEcCtD
Amprenavir—Dermatitis—Sorafenib—kidney cancer	6.6e-05	0.0011	CcSEcCtD
Amprenavir—Skin disorder—Paclitaxel—kidney cancer	6.58e-05	0.0011	CcSEcCtD
Amprenavir—Aspartate aminotransferase increased—Doxorubicin—kidney cancer	6.57e-05	0.00109	CcSEcCtD
Amprenavir—Headache—Sorafenib—kidney cancer	6.57e-05	0.00109	CcSEcCtD
Amprenavir—Diarrhoea—Dactinomycin—kidney cancer	6.53e-05	0.00109	CcSEcCtD
Amprenavir—Anorexia—Paclitaxel—kidney cancer	6.46e-05	0.00108	CcSEcCtD
Amprenavir—Alanine aminotransferase increased—Doxorubicin—kidney cancer	6.43e-05	0.00107	CcSEcCtD
Amprenavir—Vomiting—Sunitinib—kidney cancer	6.41e-05	0.00107	CcSEcCtD
Amprenavir—Tremor—Capecitabine—kidney cancer	6.38e-05	0.00106	CcSEcCtD
Amprenavir—Rash—Sunitinib—kidney cancer	6.36e-05	0.00106	CcSEcCtD
Amprenavir—Dermatitis—Sunitinib—kidney cancer	6.35e-05	0.00106	CcSEcCtD
Amprenavir—Headache—Sunitinib—kidney cancer	6.32e-05	0.00105	CcSEcCtD
Amprenavir—Nausea—Sorafenib—kidney cancer	6.23e-05	0.00104	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Paclitaxel—kidney cancer	6.17e-05	0.00103	CcSEcCtD
Amprenavir—Asthenia—Vincristine—kidney cancer	6.12e-05	0.00102	CcSEcCtD
Amprenavir—Paraesthesia—Paclitaxel—kidney cancer	6.09e-05	0.00101	CcSEcCtD
Amprenavir—Vomiting—Dactinomycin—kidney cancer	6.07e-05	0.00101	CcSEcCtD
Amprenavir—Rash—Dactinomycin—kidney cancer	6.02e-05	0.001	CcSEcCtD
Amprenavir—Nausea—Sunitinib—kidney cancer	5.99e-05	0.000997	CcSEcCtD
Amprenavir—Neutropenia—Doxorubicin—kidney cancer	5.89e-05	0.000981	CcSEcCtD
Amprenavir—Decreased appetite—Paclitaxel—kidney cancer	5.89e-05	0.00098	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Paclitaxel—kidney cancer	5.85e-05	0.000974	CcSEcCtD
Amprenavir—Fatigue—Paclitaxel—kidney cancer	5.84e-05	0.000972	CcSEcCtD
Amprenavir—Diarrhoea—Vincristine—kidney cancer	5.84e-05	0.000972	CcSEcCtD
Amprenavir—Asthenia—Gemcitabine—kidney cancer	5.81e-05	0.000966	CcSEcCtD
Amprenavir—Myalgia—Capecitabine—kidney cancer	5.8e-05	0.000965	CcSEcCtD
Amprenavir—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	5.76e-05	0.000959	CcSEcCtD
Amprenavir—Discomfort—Capecitabine—kidney cancer	5.73e-05	0.000954	CcSEcCtD
Amprenavir—Pruritus—Gemcitabine—kidney cancer	5.73e-05	0.000953	CcSEcCtD
Amprenavir—Hyperglycaemia—Doxorubicin—kidney cancer	5.69e-05	0.000946	CcSEcCtD
Amprenavir—Nausea—Dactinomycin—kidney cancer	5.67e-05	0.000944	CcSEcCtD
Amprenavir—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	5.57e-05	0.000927	CcSEcCtD
Amprenavir—Gastrointestinal pain—Paclitaxel—kidney cancer	5.54e-05	0.000922	CcSEcCtD
Amprenavir—Diarrhoea—Gemcitabine—kidney cancer	5.54e-05	0.000922	CcSEcCtD
Amprenavir—Nervous system disorder—Capecitabine—kidney cancer	5.45e-05	0.000908	CcSEcCtD
Amprenavir—Vomiting—Vincristine—kidney cancer	5.43e-05	0.000903	CcSEcCtD
Amprenavir—Skin disorder—Capecitabine—kidney cancer	5.4e-05	0.000899	CcSEcCtD
Amprenavir—Rash—Vincristine—kidney cancer	5.38e-05	0.000895	CcSEcCtD
Amprenavir—Dermatitis—Vincristine—kidney cancer	5.37e-05	0.000894	CcSEcCtD
Amprenavir—Abdominal pain—Paclitaxel—kidney cancer	5.36e-05	0.000892	CcSEcCtD
Amprenavir—Headache—Vincristine—kidney cancer	5.35e-05	0.00089	CcSEcCtD
Amprenavir—Hepatobiliary disease—Doxorubicin—kidney cancer	5.32e-05	0.000885	CcSEcCtD
Amprenavir—Anorexia—Capecitabine—kidney cancer	5.3e-05	0.000882	CcSEcCtD
Amprenavir—Vomiting—Gemcitabine—kidney cancer	5.15e-05	0.000856	CcSEcCtD
Amprenavir—Rash—Gemcitabine—kidney cancer	5.1e-05	0.000849	CcSEcCtD
Amprenavir—Dermatitis—Gemcitabine—kidney cancer	5.1e-05	0.000849	CcSEcCtD
Amprenavir—Headache—Gemcitabine—kidney cancer	5.07e-05	0.000844	CcSEcCtD
Amprenavir—Nausea—Vincristine—kidney cancer	5.07e-05	0.000843	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Capecitabine—kidney cancer	5.07e-05	0.000843	CcSEcCtD
Amprenavir—Paraesthesia—Capecitabine—kidney cancer	4.99e-05	0.000831	CcSEcCtD
Amprenavir—Connective tissue disorder—Doxorubicin—kidney cancer	4.96e-05	0.000825	CcSEcCtD
Amprenavir—Asthenia—Paclitaxel—kidney cancer	4.86e-05	0.000809	CcSEcCtD
Amprenavir—Decreased appetite—Capecitabine—kidney cancer	4.83e-05	0.000805	CcSEcCtD
Amprenavir—Nausea—Gemcitabine—kidney cancer	4.81e-05	0.0008	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Capecitabine—kidney cancer	4.8e-05	0.000799	CcSEcCtD
Amprenavir—Fatigue—Capecitabine—kidney cancer	4.79e-05	0.000798	CcSEcCtD
Amprenavir—Pruritus—Paclitaxel—kidney cancer	4.79e-05	0.000798	CcSEcCtD
Amprenavir—Erythema multiforme—Doxorubicin—kidney cancer	4.77e-05	0.000794	CcSEcCtD
Amprenavir—Cardiac disorder—Doxorubicin—kidney cancer	4.68e-05	0.000779	CcSEcCtD
Amprenavir—Diarrhoea—Paclitaxel—kidney cancer	4.64e-05	0.000772	CcSEcCtD
Amprenavir—Gastrointestinal pain—Capecitabine—kidney cancer	4.55e-05	0.000757	CcSEcCtD
Amprenavir—Mental disorder—Doxorubicin—kidney cancer	4.42e-05	0.000736	CcSEcCtD
Amprenavir—Abdominal pain—Capecitabine—kidney cancer	4.4e-05	0.000732	CcSEcCtD
Amprenavir—Malnutrition—Doxorubicin—kidney cancer	4.39e-05	0.000731	CcSEcCtD
Amprenavir—Flatulence—Doxorubicin—kidney cancer	4.33e-05	0.00072	CcSEcCtD
Amprenavir—Vomiting—Paclitaxel—kidney cancer	4.31e-05	0.000717	CcSEcCtD
Amprenavir—Rash—Paclitaxel—kidney cancer	4.27e-05	0.000711	CcSEcCtD
Amprenavir—Dermatitis—Paclitaxel—kidney cancer	4.27e-05	0.00071	CcSEcCtD
Amprenavir—Headache—Paclitaxel—kidney cancer	4.25e-05	0.000707	CcSEcCtD
Amprenavir—Nausea—Paclitaxel—kidney cancer	4.03e-05	0.00067	CcSEcCtD
Amprenavir—Asthenia—Capecitabine—kidney cancer	3.99e-05	0.000664	CcSEcCtD
Amprenavir—Pruritus—Capecitabine—kidney cancer	3.93e-05	0.000655	CcSEcCtD
Amprenavir—Diarrhoea—Capecitabine—kidney cancer	3.81e-05	0.000633	CcSEcCtD
Amprenavir—Myalgia—Doxorubicin—kidney cancer	3.74e-05	0.000622	CcSEcCtD
Amprenavir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	3.71e-05	0.000618	CcSEcCtD
Amprenavir—Discomfort—Doxorubicin—kidney cancer	3.69e-05	0.000615	CcSEcCtD
Amprenavir—Vomiting—Capecitabine—kidney cancer	3.54e-05	0.000588	CcSEcCtD
Amprenavir—Nervous system disorder—Doxorubicin—kidney cancer	3.52e-05	0.000585	CcSEcCtD
Amprenavir—Rash—Capecitabine—kidney cancer	3.51e-05	0.000584	CcSEcCtD
Amprenavir—Dermatitis—Capecitabine—kidney cancer	3.5e-05	0.000583	CcSEcCtD
Amprenavir—Headache—Capecitabine—kidney cancer	3.48e-05	0.00058	CcSEcCtD
Amprenavir—Skin disorder—Doxorubicin—kidney cancer	3.48e-05	0.000579	CcSEcCtD
Amprenavir—Anorexia—Doxorubicin—kidney cancer	3.42e-05	0.000569	CcSEcCtD
Amprenavir—Nausea—Capecitabine—kidney cancer	3.3e-05	0.00055	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Doxorubicin—kidney cancer	3.27e-05	0.000544	CcSEcCtD
Amprenavir—Paraesthesia—Doxorubicin—kidney cancer	3.22e-05	0.000536	CcSEcCtD
Amprenavir—Decreased appetite—Doxorubicin—kidney cancer	3.12e-05	0.000519	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Doxorubicin—kidney cancer	3.09e-05	0.000515	CcSEcCtD
Amprenavir—Fatigue—Doxorubicin—kidney cancer	3.09e-05	0.000514	CcSEcCtD
Amprenavir—Gastrointestinal pain—Doxorubicin—kidney cancer	2.93e-05	0.000488	CcSEcCtD
Amprenavir—Abdominal pain—Doxorubicin—kidney cancer	2.83e-05	0.000472	CcSEcCtD
Amprenavir—Asthenia—Doxorubicin—kidney cancer	2.57e-05	0.000428	CcSEcCtD
Amprenavir—Pruritus—Doxorubicin—kidney cancer	2.54e-05	0.000422	CcSEcCtD
Amprenavir—Diarrhoea—Doxorubicin—kidney cancer	2.45e-05	0.000408	CcSEcCtD
Amprenavir—Vomiting—Doxorubicin—kidney cancer	2.28e-05	0.000379	CcSEcCtD
Amprenavir—Rash—Doxorubicin—kidney cancer	2.26e-05	0.000376	CcSEcCtD
Amprenavir—Dermatitis—Doxorubicin—kidney cancer	2.26e-05	0.000376	CcSEcCtD
Amprenavir—Headache—Doxorubicin—kidney cancer	2.25e-05	0.000374	CcSEcCtD
Amprenavir—Nausea—Doxorubicin—kidney cancer	2.13e-05	0.000354	CcSEcCtD
Amprenavir—ABCB1—Metabolism—ALAD—kidney cancer	4.62e-06	0.000466	CbGpPWpGaD
Amprenavir—ABCB1—Transmembrane transport of small molecules—SLC2A1—kidney cancer	4.6e-06	0.000464	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—GPC3—kidney cancer	4.6e-06	0.000464	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—GPC3—kidney cancer	4.56e-06	0.00046	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—SLC2A1—kidney cancer	4.53e-06	0.000457	CbGpPWpGaD
Amprenavir—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—kidney cancer	4.52e-06	0.000456	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—ALDH1A1—kidney cancer	4.52e-06	0.000456	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—ST3GAL2—kidney cancer	4.51e-06	0.000455	CbGpPWpGaD
Amprenavir—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—kidney cancer	4.51e-06	0.000455	CbGpPWpGaD
Amprenavir—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—kidney cancer	4.48e-06	0.000452	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—CA2—kidney cancer	4.47e-06	0.000451	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—CA2—kidney cancer	4.43e-06	0.000447	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—ALDH1A1—kidney cancer	4.41e-06	0.000445	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	4.39e-06	0.000443	CbGpPWpGaD
Amprenavir—ABCC1—Disease—CDKN2B—kidney cancer	4.37e-06	0.000441	CbGpPWpGaD
Amprenavir—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—kidney cancer	4.36e-06	0.00044	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—ALAD—kidney cancer	4.36e-06	0.000439	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—SLC5A3—kidney cancer	4.33e-06	0.000437	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—PGK1—kidney cancer	4.33e-06	0.000437	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—ALAD—kidney cancer	4.32e-06	0.000436	CbGpPWpGaD
Amprenavir—ABCC1—Transmembrane transport of small molecules—RAF1—kidney cancer	4.32e-06	0.000435	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—ST3GAL2—kidney cancer	4.25e-06	0.000429	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—LDHB—kidney cancer	4.25e-06	0.000429	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—SLC5A3—kidney cancer	4.23e-06	0.000427	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—PGK1—kidney cancer	4.23e-06	0.000427	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—PDHB—kidney cancer	4.22e-06	0.000425	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—ST3GAL2—kidney cancer	4.22e-06	0.000425	CbGpPWpGaD
Amprenavir—CYP3A4—Biological oxidations—POMC—kidney cancer	4.2e-06	0.000424	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—ALDH1A1—kidney cancer	4.16e-06	0.000419	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—LDHB—kidney cancer	4.15e-06	0.000418	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—CRABP1—kidney cancer	4.15e-06	0.000418	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—CA9—kidney cancer	4.13e-06	0.000416	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—ALDH1A1—kidney cancer	4.12e-06	0.000416	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—CRABP1—kidney cancer	4.05e-06	0.000409	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	4.03e-06	0.000407	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—SLC5A3—kidney cancer	3.98e-06	0.000402	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—PGK1—kidney cancer	3.98e-06	0.000402	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—CCBL1—kidney cancer	3.96e-06	0.0004	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—PGK1—kidney cancer	3.95e-06	0.000398	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—SLC5A3—kidney cancer	3.95e-06	0.000398	CbGpPWpGaD
Amprenavir—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	3.94e-06	0.000398	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—LDHB—kidney cancer	3.91e-06	0.000394	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—LDHB—kidney cancer	3.87e-06	0.000391	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—ITPR2—kidney cancer	3.85e-06	0.000389	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	3.83e-06	0.000386	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—GSTP1—kidney cancer	3.78e-06	0.000381	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—ITPR2—kidney cancer	3.77e-06	0.00038	CbGpPWpGaD
Amprenavir—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	3.73e-06	0.000376	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—CA9—kidney cancer	3.68e-06	0.000372	CbGpPWpGaD
Amprenavir—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	3.63e-06	0.000366	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	3.6e-06	0.000363	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—CA9—kidney cancer	3.6e-06	0.000363	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—ABCB1—kidney cancer	3.57e-06	0.000361	CbGpPWpGaD
Amprenavir—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	3.55e-06	0.000358	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—GSTT1—kidney cancer	3.51e-06	0.000354	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—ACHE—kidney cancer	3.51e-06	0.000354	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—CRABP1—kidney cancer	3.51e-06	0.000354	CbGpPWpGaD
Amprenavir—ABCC1—Disease—HIF1A—kidney cancer	3.49e-06	0.000352	CbGpPWpGaD
Amprenavir—ABCC1—Disease—TSC2—kidney cancer	3.48e-06	0.000351	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—GSTM1—kidney cancer	3.47e-06	0.00035	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—PPAT—kidney cancer	3.44e-06	0.000347	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—GLIPR1—kidney cancer	3.44e-06	0.000347	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—GSTT1—kidney cancer	3.43e-06	0.000346	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—ACHE—kidney cancer	3.43e-06	0.000346	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—CA9—kidney cancer	3.39e-06	0.000342	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—CA9—kidney cancer	3.36e-06	0.000339	CbGpPWpGaD
Amprenavir—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	3.35e-06	0.000338	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—SCARB1—kidney cancer	3.33e-06	0.000336	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—PTGS1—kidney cancer	3.29e-06	0.000332	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—CYP1A1—kidney cancer	3.29e-06	0.000332	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	3.28e-06	0.000331	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—ITPR2—kidney cancer	3.26e-06	0.000329	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—SCARB1—kidney cancer	3.25e-06	0.000328	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—PSMD7—kidney cancer	3.23e-06	0.000326	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—PTGS1—kidney cancer	3.22e-06	0.000325	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—APRT—kidney cancer	3.2e-06	0.000322	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—FH—kidney cancer	3.2e-06	0.000322	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—PSMD7—kidney cancer	3.16e-06	0.000318	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—CRABP1—kidney cancer	3.13e-06	0.000316	CbGpPWpGaD
Amprenavir—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	3.08e-06	0.000311	CbGpPWpGaD
Amprenavir—ABCC1—Disease—KIT—kidney cancer	3.08e-06	0.00031	CbGpPWpGaD
Amprenavir—ABCC1—Disease—APC—kidney cancer	3.08e-06	0.00031	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—BCHE—kidney cancer	3.06e-06	0.000309	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—CRABP1—kidney cancer	3.06e-06	0.000308	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—SLC5A5—kidney cancer	3.02e-06	0.000305	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism of lipids and lipoproteins—POMC—kidney cancer	3.01e-06	0.000303	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—GPC3—kidney cancer	3e-06	0.000303	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—BCHE—kidney cancer	2.99e-06	0.000302	CbGpPWpGaD
Amprenavir—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	2.98e-06	0.0003	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—ACHE—kidney cancer	2.98e-06	0.0003	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—GSTT1—kidney cancer	2.98e-06	0.0003	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—SLC5A5—kidney cancer	2.96e-06	0.000298	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—CA2—kidney cancer	2.92e-06	0.000295	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—SLC2A1—kidney cancer	2.92e-06	0.000295	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—ITPR2—kidney cancer	2.91e-06	0.000294	CbGpPWpGaD
Amprenavir—ABCC1—Disease—BRAF—kidney cancer	2.89e-06	0.000292	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—CRABP1—kidney cancer	2.88e-06	0.000291	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—CRABP1—kidney cancer	2.86e-06	0.000288	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—SLC2A1—kidney cancer	2.85e-06	0.000288	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—ALAD—kidney cancer	2.85e-06	0.000287	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—ITPR2—kidney cancer	2.84e-06	0.000287	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—SCARB1—kidney cancer	2.82e-06	0.000284	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—PTGS1—kidney cancer	2.79e-06	0.000281	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—ST3GAL2—kidney cancer	2.78e-06	0.00028	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—PSMD7—kidney cancer	2.73e-06	0.000276	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—ALDH1A1—kidney cancer	2.72e-06	0.000274	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.7e-06	0.000273	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism of lipids and lipoproteins—POMC—kidney cancer	2.68e-06	0.000271	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—ITPR2—kidney cancer	2.68e-06	0.00027	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—ACHE—kidney cancer	2.66e-06	0.000268	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—GSTT1—kidney cancer	2.66e-06	0.000268	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—ITPR2—kidney cancer	2.66e-06	0.000268	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—PGK1—kidney cancer	2.61e-06	0.000263	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—SLC5A3—kidney cancer	2.61e-06	0.000263	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—GSTT1—kidney cancer	2.59e-06	0.000261	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—ACHE—kidney cancer	2.59e-06	0.000261	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—BCHE—kidney cancer	2.59e-06	0.000261	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—SLC5A5—kidney cancer	2.56e-06	0.000258	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—LDHB—kidney cancer	2.55e-06	0.000258	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—SCARB1—kidney cancer	2.51e-06	0.000254	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—PTGS1—kidney cancer	2.49e-06	0.000251	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—SLC2A1—kidney cancer	2.47e-06	0.000249	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—SCARB1—kidney cancer	2.45e-06	0.000247	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—POMC—kidney cancer	2.45e-06	0.000247	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism of lipids and lipoproteins—POMC—kidney cancer	2.45e-06	0.000247	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—ACHE—kidney cancer	2.44e-06	0.000246	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—GSTT1—kidney cancer	2.44e-06	0.000246	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—PSMD7—kidney cancer	2.44e-06	0.000246	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—GSTP1—kidney cancer	2.44e-06	0.000246	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—PTGS1—kidney cancer	2.43e-06	0.000245	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—GSTT1—kidney cancer	2.42e-06	0.000244	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—ACHE—kidney cancer	2.42e-06	0.000244	CbGpPWpGaD
Amprenavir—ABCC1—Disease—RAF1—kidney cancer	2.41e-06	0.000244	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	2.4e-06	0.000242	CbGpPWpGaD
Amprenavir—ABCC1—Disease—ERBB2—kidney cancer	2.39e-06	0.000241	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—PSMD7—kidney cancer	2.38e-06	0.00024	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—GSTP1—kidney cancer	2.38e-06	0.00024	CbGpPWpGaD
Amprenavir—ABCC1—Disease—MTOR—kidney cancer	2.36e-06	0.000238	CbGpPWpGaD
Amprenavir—ABCC1—Disease—CD4—kidney cancer	2.35e-06	0.000237	CbGpPWpGaD
Amprenavir—ABCC1—Disease—PTGS2—kidney cancer	2.34e-06	0.000236	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—BCHE—kidney cancer	2.31e-06	0.000233	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—SCARB1—kidney cancer	2.31e-06	0.000233	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—ABCB1—kidney cancer	2.31e-06	0.000233	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—SCARB1—kidney cancer	2.29e-06	0.000231	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—PTGS1—kidney cancer	2.29e-06	0.000231	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—SLC5A5—kidney cancer	2.29e-06	0.00023	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—PTGS1—kidney cancer	2.27e-06	0.000229	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—BCHE—kidney cancer	2.26e-06	0.000228	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—ABCB1—kidney cancer	2.25e-06	0.000227	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—PSMD7—kidney cancer	2.24e-06	0.000226	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—GSTM1—kidney cancer	2.24e-06	0.000226	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—SLC5A5—kidney cancer	2.23e-06	0.000225	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—PSMD7—kidney cancer	2.23e-06	0.000224	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—CA9—kidney cancer	2.22e-06	0.000223	CbGpPWpGaD
Amprenavir—ABCC1—Disease—CDKN1B—kidney cancer	2.21e-06	0.000223	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—SLC2A1—kidney cancer	2.21e-06	0.000223	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—GSTM1—kidney cancer	2.19e-06	0.000221	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—SLC2A1—kidney cancer	2.15e-06	0.000217	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	2.14e-06	0.000216	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—BCHE—kidney cancer	2.13e-06	0.000215	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—CYP1A1—kidney cancer	2.12e-06	0.000214	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—BCHE—kidney cancer	2.11e-06	0.000213	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—SLC5A5—kidney cancer	2.1e-06	0.000212	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	2.09e-06	0.000211	CbGpPWpGaD
Amprenavir—ABCC1—Disease—CTNNB1—kidney cancer	2.09e-06	0.000211	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—SLC5A5—kidney cancer	2.08e-06	0.00021	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—CYP1A1—kidney cancer	2.07e-06	0.000209	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—GSTP1—kidney cancer	2.06e-06	0.000208	CbGpPWpGaD
Amprenavir—ABCB1—Transmembrane transport of small molecules—RAF1—kidney cancer	2.05e-06	0.000207	CbGpPWpGaD
Amprenavir—ABCC1—Disease—PTEN—kidney cancer	2.04e-06	0.000205	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—SLC2A1—kidney cancer	2.03e-06	0.000205	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—SLC2A1—kidney cancer	2.01e-06	0.000203	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—PTGS2—kidney cancer	1.96e-06	0.000197	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.95e-06	0.000197	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—ABCB1—kidney cancer	1.95e-06	0.000197	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—GSTM1—kidney cancer	1.89e-06	0.000191	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—CRABP1—kidney cancer	1.88e-06	0.00019	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.87e-06	0.000188	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—GSTP1—kidney cancer	1.84e-06	0.000186	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—GSTP1—kidney cancer	1.8e-06	0.000181	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—CYP1A1—kidney cancer	1.8e-06	0.000181	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—ITPR2—kidney cancer	1.75e-06	0.000177	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—ABCB1—kidney cancer	1.74e-06	0.000176	CbGpPWpGaD
Amprenavir—ABCC1—Disease—MAPK3—kidney cancer	1.74e-06	0.000176	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—PTEN—kidney cancer	1.71e-06	0.000172	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.7e-06	0.000172	CbGpPWpGaD
Amprenavir—ABCC1—Disease—MYC—kidney cancer	1.69e-06	0.000171	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—GSTP1—kidney cancer	1.69e-06	0.000171	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—GSTM1—kidney cancer	1.69e-06	0.000171	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—GSTP1—kidney cancer	1.68e-06	0.000169	CbGpPWpGaD
Amprenavir—ABCC1—Disease—MAPK1—kidney cancer	1.66e-06	0.000167	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—GSTM1—kidney cancer	1.65e-06	0.000167	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—CYP1A1—kidney cancer	1.6e-06	0.000162	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—ABCB1—kidney cancer	1.6e-06	0.000162	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—ACHE—kidney cancer	1.6e-06	0.000161	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—GSTT1—kidney cancer	1.6e-06	0.000161	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—ABCB1—kidney cancer	1.59e-06	0.00016	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—POMC—kidney cancer	1.58e-06	0.00016	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—CYP1A1—kidney cancer	1.57e-06	0.000158	CbGpPWpGaD
Amprenavir—ABCC1—Disease—KRAS—kidney cancer	1.56e-06	0.000158	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—GSTM1—kidney cancer	1.56e-06	0.000157	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—POMC—kidney cancer	1.55e-06	0.000156	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—GSTM1—kidney cancer	1.54e-06	0.000156	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—SCARB1—kidney cancer	1.51e-06	0.000152	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—PTGS1—kidney cancer	1.5e-06	0.000151	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.48e-06	0.000149	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—CYP1A1—kidney cancer	1.47e-06	0.000149	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—PSMD7—kidney cancer	1.47e-06	0.000148	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—CYP1A1—kidney cancer	1.46e-06	0.000147	CbGpPWpGaD
Amprenavir—ABCC1—Disease—PIK3CA—kidney cancer	1.44e-06	0.000145	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—BCHE—kidney cancer	1.39e-06	0.00014	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—SLC5A5—kidney cancer	1.37e-06	0.000139	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—POMC—kidney cancer	1.34e-06	0.000135	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—SLC2A1—kidney cancer	1.33e-06	0.000134	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.32e-06	0.000133	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—PTGS2—kidney cancer	1.26e-06	0.000127	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—PTGS2—kidney cancer	1.23e-06	0.000124	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—PIK3CA—kidney cancer	1.2e-06	0.000121	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.2e-06	0.000121	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—POMC—kidney cancer	1.2e-06	0.000121	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—POMC—kidney cancer	1.17e-06	0.000118	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—GSTP1—kidney cancer	1.11e-06	0.000112	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—PTEN—kidney cancer	1.1e-06	0.000111	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—POMC—kidney cancer	1.1e-06	0.000111	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—POMC—kidney cancer	1.09e-06	0.00011	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—PTEN—kidney cancer	1.08e-06	0.000108	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—PTGS2—kidney cancer	1.07e-06	0.000108	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—ABCB1—kidney cancer	1.05e-06	0.000106	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—GSTM1—kidney cancer	1.02e-06	0.000103	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—CYP1A1—kidney cancer	9.64e-07	9.73e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—PTGS2—kidney cancer	9.54e-07	9.62e-05	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—PTEN—kidney cancer	9.32e-07	9.4e-05	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—PTGS2—kidney cancer	9.31e-07	9.39e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—PTGS2—kidney cancer	8.77e-07	8.85e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—PTGS2—kidney cancer	8.69e-07	8.77e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—PTEN—kidney cancer	8.32e-07	8.39e-05	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—PTEN—kidney cancer	8.12e-07	8.19e-05	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—PIK3CA—kidney cancer	7.76e-07	7.83e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—PTEN—kidney cancer	7.65e-07	7.71e-05	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—PIK3CA—kidney cancer	7.59e-07	7.65e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—PTEN—kidney cancer	7.58e-07	7.65e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—POMC—kidney cancer	7.19e-07	7.25e-05	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—PIK3CA—kidney cancer	6.57e-07	6.63e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—PIK3CA—kidney cancer	5.87e-07	5.92e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—PTGS2—kidney cancer	5.73e-07	5.78e-05	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—PIK3CA—kidney cancer	5.73e-07	5.78e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—PIK3CA—kidney cancer	5.4e-07	5.44e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—PIK3CA—kidney cancer	5.35e-07	5.4e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—PTEN—kidney cancer	5e-07	5.04e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—PIK3CA—kidney cancer	3.53e-07	3.56e-05	CbGpPWpGaD
